Tandem Diabetes Care (TNDM) had the highest return between November 1, 2017 and December 30, 2019 by a mid-cap US stock, returning 2,281.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
Tandem Diabetes Care (TNDM) | 11/1/2017 - 12/30/2019 | 2,281.78% |
Axsome Therapeutics (AXSM) | 11/1/2017 - 12/30/2019 | 2,085.89% |
Arrowhead Pharmaceuticals (ARWR) | 11/1/2017 - 12/30/2019 | 1,658.9% |
Enphase Energy (ENPH) | 11/1/2017 - 12/30/2019 | 1,558.17% |
Krystal Biotech (KRYS) | 11/1/2017 - 12/30/2019 | 516.43% |
Boot Barn (BOOT) | 11/1/2017 - 12/30/2019 | 443.13% |
Xenon Pharmaceuticals (XENE) | 11/1/2017 - 12/30/2019 | 306.15% |
Crocs (CROX) | 11/1/2017 - 12/30/2019 | 306.07% |
Ascendis Pharma A-S (ASND) | 11/1/2017 - 12/30/2019 | 299.32% |
Ringcentral (RNG) | 11/1/2017 - 12/30/2019 | 292.42% |
Novocure (NVCR) | 11/1/2017 - 12/30/2019 | 292% |
Vericel Corp Ord (VCEL) | 11/1/2017 - 12/30/2019 | 283.33% |
Freedom (FRHC) | 11/1/2017 - 12/30/2019 | 274.87% |
Freshpet (FRPT) | 11/1/2017 - 12/30/2019 | 270.64% |
Goosehead Insurance (GSHD) | 11/1/2017 - 12/30/2019 | 258.68% |
Amedisys (AMED) | 11/1/2017 - 12/30/2019 | 249.13% |
Viking Therapeutics (VKTX) | 11/1/2017 - 12/30/2019 | 233.19% |
Veracyte (VCYT) | 11/1/2017 - 12/30/2019 | 230.81% |
GDS (GDS) | 11/1/2017 - 12/30/2019 | 223.97% |
Lattice Semiconductor (LSCC) | 11/1/2017 - 12/30/2019 | 223.39% |
Match (MTCH) | 11/1/2017 - 12/30/2019 | 223.39% |
Crispr Therapeutics (CRSP) | 11/1/2017 - 12/30/2019 | 218.76% |
Rapid7 (RPD) | 11/1/2017 - 12/30/2019 | 211.61% |
Inspire Medical Systems (INSP) | 11/1/2017 - 12/30/2019 | 200.24% |
Wingstop (WING) | 11/1/2017 - 12/30/2019 | 188.54% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
